APA (7th ed.) Citation

G, L., J, K., X, L., L, Z., Y, C., C, G., . . . B, Z. (2026). CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: Mechanistic insights and development of a CYP4B1-related prognostic signature. Frontiers in oncology, 15, 1661650. https://doi.org/10.3389/fonc.2025.1661650

Chicago Style (17th ed.) Citation

G, Li, Kang J, Li X, Zhao L, Chen Y, Gong C, Liu Z, and Zhang B. "CYP4B1 Inhibits Lung Adenocarcinoma Progression via PI3K/AKT/mTOR Pathway: Mechanistic Insights and Development of a CYP4B1-related Prognostic Signature." Frontiers in Oncology 15 (2026): 1661650. https://doi.org/10.3389/fonc.2025.1661650.

MLA (9th ed.) Citation

G, Li, et al. "CYP4B1 Inhibits Lung Adenocarcinoma Progression via PI3K/AKT/mTOR Pathway: Mechanistic Insights and Development of a CYP4B1-related Prognostic Signature." Frontiers in Oncology, vol. 15, 2026, p. 1661650, https://doi.org/10.3389/fonc.2025.1661650.